Literature DB >> 8490170

Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIa.

L V Rao1, S I Rapaport, A D Hoang.   

Abstract

Because free factor VIIa is inactivated only very slowly by a plasma concentration of antithrombin III (AT III) even in the presence of heparin, it has been assumed that AT III plays no significant role in regulating the initiation of tissue factor-dependent blood coagulation. However, in the present study, we present evidence that factor VIIa bound to tissue factor, unlike free factor VIIa, is readily inactivated by AT III in the presence of heparin. In a reaction mixture containing calcium ions and approximately equimolar concentrations of relipidated tissue factor (8.9 nmol/L) and factor VIIa (10 nmol/L), AT III (100 micrograms/mL) plus heparin (1 U/mL) inhibited 50% of the factor VIIa coagulant activity of the reaction mixture within 5 minutes. AT III/heparin was also shown to inhibit the catalytic activity towards factor X of factor VIIa/tissue factor complexes formed on monolayers of an ovarian carcinoma cell line (OC-2008) that constitutively expresses surface membrane tissue factor. AT III, even in the absence of exogenously added heparin, substantially inhibited the functional activity of factor VIIa/cell surface tissue factor complexes on intact monolayers. AT III alone and AT III/heparin, to a greater extent, also inhibited factor VIIa on "nonfunctional" factor VIIa/tissue factor complexes on intact monolayers, with resultant inhibition of their expression of factor VIIa/tissue factor catalytic activity toward factor X after cell lysis. The potential physiologic significance of these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8490170

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

1.  Factor VIIa binding and internalization in hepatocytes.

Authors:  G Hjortoe; B B Sorensen; L C Petersen; L V M Rao
Journal:  J Thromb Haemost       Date:  2005-10       Impact factor: 5.824

2.  Relationships of plasma factor VIIa-antithrombin complexes to manifest and future cardiovascular disease.

Authors:  Angela Silveira; Daniela Scanavini; Susanna Boquist; Carl-Göran Ericsson; Mai-Lis Hellénius; Karin Leander; Ulf de Faire; John Ohrvik; Barry Woodhams; James H Morrissey; Anders Hamsten
Journal:  Thromb Res       Date:  2011-09-16       Impact factor: 3.944

3.  Contribution of exosite occupancy by heparin to the regulation of coagulation proteases by antithrombin.

Authors:  L Yang; C Manithody; S H Qureshi; A R Rezaie
Journal:  Thromb Haemost       Date:  2009-12-18       Impact factor: 5.249

4.  Plasminogen activator inhibitor-1 inhibits factor VIIa bound to tissue factor.

Authors:  P Sen; A A Komissarov; G Florova; S Idell; U R Pendurthi; L Vijaya Mohan Rao
Journal:  J Thromb Haemost       Date:  2011-03       Impact factor: 5.824

5.  Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistance.

Authors:  YouFu Li; Miguel Rodriquez; Frederick A Spencer; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2002-10       Impact factor: 2.300

Review 6.  How it all starts: Initiation of the clotting cascade.

Authors:  Stephanie A Smith; Richard J Travers; James H Morrissey
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-05-28       Impact factor: 8.250

7.  Interaction of antithrombin with sulfated, low molecular weight lignins: opportunities for potent, selective modulation of antithrombin function.

Authors:  Brian L Henry; Justin Connell; Aiye Liang; Chandravel Krishnasamy; Umesh R Desai
Journal:  J Biol Chem       Date:  2009-06-04       Impact factor: 5.157

8.  Mechanism of the Ca2+-induced enhancement of the intrinsic factor VIIa activity.

Authors:  Jais R Bjelke; Ole H Olsen; Michel Fodje; L Anders Svensson; Susanne Bang; Gert Bolt; Birthe B Kragelund; Egon Persson
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

Review 9.  Tissue Factor-Factor VII Complex As a Key Regulator of Ovarian Cancer Phenotypes.

Authors:  Shiro Koizume; Yohei Miyagi
Journal:  Biomark Cancer       Date:  2015-09-06

10.  Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes. A potential mechanism for localized control of blood coagulation.

Authors:  M P McGee; S Foster; X Wang
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.